Earnings Call Insights: Celcuity Inc. (CELC) Q4 2025
Management View
-
CEO Brian Sullivan highlighted that 2025 was pivotal for Celcuity, stating the company is preparing for “the potential approval and commercialization of gedatolisib.” He reviewed several milestones: “the FDA accepted our new drug application…granted
Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
